AF
KZR

Amalgamated Financial’s Kezar Life Sciences KZR Stock Holding History

Amalgamated Financial’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$70K Buy
+421
New +$60.4K ﹤0.01% 2268

Other funds holding KZR

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Amalgamated Financial's KZR Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Kezar Life Sciences (KZR) in Q1 2022: 421 shares worth $70K. The stake represents ﹤0.01% of the portfolio and ranks #2268 among its holdings.

123 funds tracked by Wall St. Rank hold KZR as of Q1 2022.

  • Amalgamated Financial held 421 shares of Kezar Life Sciences worth $70K as of Q1 2022.
  • Kezar Life Sciences was a new Amalgamated Financial position in Q1 2022.
  • Kezar Life Sciences made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2268 holding.
  • 123 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.